| Literature DB >> 32369297 |
Yusuf Kenan Tekin1, Gülacan Tekin2.
Abstract
OBJECTIVE: Ascending thoracic aortic aneurysm (ATAA), seen in adults, is an important cause of morbidity and mortality. In this study, we aimed to evaluate the levels of mean platelet volume (MPV), mean platelet volume-to-platelet count ratio (MPVPCR), mean platelet volume-to-lymphocyte ratio (MPVLR), and red cell distribution width platelet count ratio (RDWPCR) in patients with thoracic aortic aneurysm.Entities:
Keywords: Blood Platelets; C-Reactive Protein; Inflammation; Lymphocyte; Mean Platelet Volume; Neutrophils; Platelet Count; Thoracic Aortic Aneurysm
Mesh:
Substances:
Year: 2020 PMID: 32369297 PMCID: PMC7199975 DOI: 10.21470/1678-9741-2019-0348
Source DB: PubMed Journal: Braz J Cardiovasc Surg ISSN: 0102-7638
Demographic characteristics of the case group versus control group.
| Characteristics | Case group | Control group | ||
|---|---|---|---|---|
| Age, years (mean±SD) | 70.83±11.1 | 70.56±9.4 | 0.816 | |
| ATAA (mean±SD) | 42.3±2.7 | 35.8±3.2 | <0.001 | |
| Gender | Male | 57 (54.3) | 105 (53.6) | 0.906 |
| Female | 48 (45.7) | 91 (46.4) | ||
| Diabetes mellitus | Present | 35 (17.9) | 12 (11.4) | 0.143 |
| Absent | 161 (82.1) | 93 (88.6) | ||
| Hypertension | Present | 47 (44.8) | 84 (42.9) | 0.751 |
| Absent | 58 (55.2) | 112 (57.1) | ||
Student t-test
ATAA=ascending thoracic aortic aneurysm
Mean and median values of blood parameters of the case group versus control group.
| Variables | Case group | Control group | Student |
|---|---|---|---|
| White blood cell | 6.8 (5.4-8.7) | 7.2 (4.6-11.2) | 0.414 |
| Hemoglobin (g/dL) | 12.9±1.9 | 13.4±1.6 | 0.054 |
| Platelets | 201.0 (168.0-253.0) | 254.0 (214.0-298.3) | <0.001 |
| Neutrophils | 4.6 (3.4-5.8) | 4.3 (3.6-5.3) | 0.062 |
| Lymphocytes | 1.4 (1.0-1.8) | 1.7 (1.4-2.3) | <0.001 |
| Monocytes | 0.5 (0.3-0.6) | 0.5 (0.4-0.6) | 0,086 |
| MPV (fL) | 9.7±1.1 | 9.2±0.8 | <0.001 |
| MCV (fL) | 86.4±6.5 | 86.7±5.8 | 0.674 |
| RDW (%) | 15.2±2.0 | 14.6±2.0 | 0.300 |
| PLR | 201.8±153.2 | 155.1±61.4 | 0.071 |
| LMR | 3.6±2.4 | 4.3±1.9 | 0.125 |
| MPVPCR | 0.05±0.02 | 0.04±0.01 | <0.001 |
| MPVLR | 9.18±6.8 | 5.6±1.9 | <0.001 |
| RDWPCR | 0.08±0.06 | 0.06±0.02 | 0.013 |
| hs-CRP | 14.1±6.0 | 1.6±1.06 | <0.001 |
Data are presented as median with interquartile range;
Mann-Whitney U test.
hs-CRP=high-sensitivity C-reactive protein; LMR=lymphocyte-to-monocyte ratio; MCV=mean corpuscular volume; MPV=mean platelet volume; MPVPCR=mean platelet volume-to-platelet count ratio; MPVLR=mean platelet volume-to-lymphocyte ratio; PLR=platelet-to-lymphocyte ratio; RDW=red cell distribution width; RDWPCR=red cell distribution width-to-platelet count ratio
Cutoff values, sensitivity and specificity of MPV, MPVLR, MPVPCR and RDWPCR for predicting marker chronic inflammatory of ATAA.
| MPV | MPVLR | MPVPCR | RDWPCR | |
|---|---|---|---|---|
| Cutoff value | 9.35 | 5.55 | 0.04 | 0.07 |
| Sensitivity | 0.62 | 0.72 | 0.80 | 0.68 |
| Specificity | 0.58 | 0.61 | 0.48 | 0.72 |
| AUC (95% CI) | 0.631 (0,563-0,700) | 0.719 (0.657-0.780) | 0.698 (0.633-0.763) | 0.729 (0.666-0.792) |
ATAA=ascending thoracic aortic aneurysm; AUC=area under the curve; CI=confidence interval; MPV=mean platelet volume; MPVLR=mean platelet volume-to-lymphocyte ratio; MPVPCR=mean platelet volume-to-platelet count ratio; RDWPCR=red cell distribution width-to-platelet count ratio
Fig. 1Mean platelet volume (MPV), mean platelet volume-toplatelet count ratio (MPVPCR), mean platelet volume-to-lymphocyte ratio (MPVLR).
Fig. 2Red cell distribution width platelet count ratio.
| Abbreviations, acronyms & symbols | ||||
|---|---|---|---|---|
| AA | = Aortic aneurysm | MPVPCR | = Mean platelet volume-to-platelet count ratio | |
| ATAA | = Ascending thoracic aortic aneurysm | PLR | = Platelet-to-lymphocyte ratio | |
| AUC | = Area under the curve | RDWPCR | = Red cell distribution width-to-platelet count ratio | |
| COPD | = Chronic obstructive pulmonary disease | ROC | = Receiver operating characteristic | |
| DM | = Diabetes mellitus | SD | = Standard deviation | |
| ED | = Emergency department | SLE | = Systemic lupus erythematosus | |
| hs-CRP | = High-sensitivity C-reactive protein | SPSS | = Statistical Package for the Social Sciences | |
| LMR | = Lymphocyte-to-monocyte ratio | STEMI | = ST-segment elevation myocardial infarction | |
| MPV | = Mean platelet volume | TAA | = Thoracic aortic aneurysm | |
| MPVLR | = Mean platelet volume-to-lymphocyte ratio | |||
| Authors' roles & responsibilities | |
|---|---|
| YKT | Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; drafting the work or revising it critically for important intellectual content; final approval of the version to be published |
| GT | Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; drafting the work or revising it critically for important intellectual content; final approval of the version to be published |